Nuwellis, Inc. Announces Adjournment of Annual Meeting of Stockholders Due to Lack of Quorum
May 17 2022 - 4:25PM
Nuwellis, Inc. (NASDAQ: NUWE), today announced that the Company’s
2022 Annual Meeting of Stockholders, on May 17, 2022 at 2:00 p.m.,
was convened and adjourned, without any business being conducted,
due to lack of the required quorum.
A quorum consists of a majority of the outstanding shares
entitled to vote. There were fewer than a majority of outstanding
shares entitled to vote, either present virtually or represented by
proxy, at the Annual Meeting. The Annual Meeting therefore had no
quorum and was adjourned to 2:00 p.m. Central Time on May 25, 2022
at https://web.lumiagm.com/257409059 (password: nuwellis2022) to
allow additional time for the Company’s stockholders to vote on the
proposals set forth in the Company’s definitive proxy statement
filed with the Securities and Exchange Commission on April 11,
2022.
During the period of adjournment, the Company will continue to
solicit votes from its stockholders with respect to the proposals
set forth in the proxy statement.
Only stockholders of record as of the record date, March 30,
2022, are entitled to and are being requested to vote. At the time
the Annual Meeting was adjourned, proxies had been submitted by
stockholders representing approximately 49.23% of the shares of the
Company’s common stock outstanding and entitled to vote at the
Annual Meeting. Proxies previously submitted in respect of the
Annual Meeting will be voted at the adjourned Annual Meeting unless
properly revoked, and stockholders who have previously submitted a
proxy or otherwise voted need not take any action.
The Company encourages all stockholders of record on March 30,
2022 who have not yet voted to do so before Tuesday, May 24, 2022
at 11:59 p.m., Eastern Time.
Important InformationThis
material may be deemed to be solicitation material in respect of
the Annual Meeting to be reconvened and held on Wednesday, May 25,
2022. In connection with the Annual Meeting, the Company filed a
definitive proxy statement with the SEC on April 11, 2022. BEFORE
MAKING ANY VOTING DECISIONS, STOCKHOLDERS ARE URGED TO READ THE
DEFINITIVE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED
WITH THE SEC, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE
ANNUAL MEETING. The definitive proxy statement was mailed to
stockholders who are entitled to vote at the Annual Meeting. No
changes have been made in the proposals to be voted on by
stockholders at the Annual Meeting. The Company’s proxy statement
and any other materials filed by the Company with the SEC can be
obtained free of charge at the SEC’s website at sec.gov or at
www.proxyvote.com.
About NuwellisNuwellis, Inc. (Nasdaq: NUWE) is
a medical device company dedicated to transforming the lives of
patients suffering from fluid overload through science,
collaboration, and innovation. The company is focused on
developing, manufacturing, and commercializing the Aquadex
SmartFlow® system for ultrafiltration therapy. Nuwellis is
headquartered in Minneapolis, Minn., with a wholly-owned subsidiary
in Ireland.
About the Aquadex SmartFlow SystemThe Aquadex
SmartFlow system delivers clinically proven therapy using a simple,
flexible and smart method of removing excess fluid from patients
suffering from hypervolemia (fluid overload). The Aquadex SmartFlow
system is indicated for temporary (up to 8 hours) or extended
(longer than 8 hours in patients who require hospitalization) use
in adult and pediatric patients weighing 20 kg or more whose fluid
overload is unresponsive to medical management, including
diuretics. All treatments must be administered by a health care
provider, within an outpatient or inpatient clinical setting, under
physician prescription, both having received training in
extracorporeal therapies.
CONTACTS
INVESTORS:
George Montague
Chief Financial Officer
Nuwellis, Inc.
IR@Nuwellis.com
Matt Basco, CFA
Gilmartin Group LLC
Matt.basco@gilmartinir.com
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Newellis (NASDAQ:NUWE)
Historical Stock Chart
From Jul 2023 to Jul 2024